| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Decitabine | FAERS: 9 | US FAERS | |
| 2 | Sunitinib | FAERS: 8 | OFFSIDES US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 4 | Isotretinoin | FAERS: 2 | US FAERS | |
| 5 | Dasatinib | FAERS: 1 | US FAERS | |
| 6 | Etodolac | FAERS: 1 | US FAERS | |
| 7 | Irinotecan | FAERS: 1 | US FAERS | |
| 8 | Norgestrel | FAERS: 1 | US FAERS | |
| 9 | Penicillin G Benzathine | FAERS: 1 | US FAERS | |
| 10 | Rivastigmine | FAERS: 1 | US FAERS | |
| 11 | Sorafenib | FAERS: 1 | US FAERS | |
| 12 | ledipasvir, sofosbuvir drug combination | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | obeticholic acid | FAERS: 1 | US FAERS | |
| 14 | Capecitabine | OFFSIDES | ||
| 15 | Cytarabine | OFFSIDES | ||
| 16 | Sunitinib | OFFSIDES | ||
| 17 | Tretinoin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.